Company

FesariusTherapeutics intends to further develop the patent-pending microstructure-containing gel scaffold technology for the acellular dermal replacement and wound care markets through the launch of its product family. The first item the company plans to market is a set of engineered tissue scaffold products for the skin and dermal layers. The advancement of such products aim to benefit those with wounds resulting from burns, plastic surgery, tumor removal, and other forms of trauma.